Corbus Pharmaceuticals Holdings, Inc. (CRBP) SEC filings
CRBP SEC filings moved a median of +0.69% by the close. CRBP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CRBP overview →
86 measured CRBP SEC filing events.
Where these CRBP SEC filings landedvs 85 measured CRBP SEC filing reactions
| Middle 50% of CRBP SEC filing reactions | -3.33% to +4.07% |
|---|---|
| Median reaction (to close) | +0.69% |
| Measured reactions | 85 |
Point-in-time · zero look-ahead
Half of the 85 CRBP SEC filing events with a measured close landed between -3.33% and +4.07%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Corbus Pharmaceuticals For: Sep 14 | SEC filing · Form 8-K | -0.76% | +1.89% | |
| Form 10-Q Corbus Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +3.23% | +4.42% | |
| Form 8-K Corbus Pharmaceuticals For: Aug 06 | SEC filing · Form 8-K | +0.49% | +5.41% | |
| Form 8-K Corbus Pharmaceuticals For: Jul 02 | SEC filing · Form 8-K | -1.02% | -3.74% | |
| Form S-8 Corbus Pharmaceuticals | SEC filing · Form S-8 | +0.97% | +0.00% | |
| Form S-8 Corbus Pharmaceuticals | SEC filing · Form S-8 | -2.04% | -1.40% | |
| Form 8-K Corbus Pharmaceuticals For: May 26 | SEC filing · Form 8-K | -7.18% | -18.87% | |
| Form 8-K Corbus Pharmaceuticals For: May 19 | SEC filing · Form 8-K | +0.30% | +16.26% | |
| Form 8-K Corbus Pharmaceuticals For: May 13 | SEC filing · Form 8-K | -0.49% | -1.96% | |
| Form 10-Q Corbus Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -2.55% | +6.11% | |
| Form 8-K Corbus Pharmaceuticals For: May 12 | SEC filing · Form 8-K | +2.04% | +1.60% | |
| Form 8-K Corbus Pharmaceuticals For: Apr 15 | SEC filing · Form 8-K | -0.29% | +3.32% | |
| Form DEFA14A Corbus Pharmaceuticals | SEC filing · Form DEFA14A | -0.29% | +3.32% | |
| Form 8-K Corbus Pharmaceuticals For: Apr 14 | SEC filing · Form 8-K | +0.89% | -1.28% | |
| Form 8-K Corbus Pharmaceuticals For: Apr 01 | SEC filing · Form 8-K | +0.00% | -2.80% | |
| Form ARS Corbus Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +0.87% | -2.12% | |
| Form DEF 14A Corbus Pharmaceuticals For: Apr 01 | SEC filing · Form DEF | +0.87% | -2.12% | |
| Form DEFA14A Corbus Pharmaceuticals | SEC filing · Form DEFA14A | +0.87% | -2.12% | |
| Form EFFECT Corbus Pharmaceuticals | SEC filing · Form EFFECT | +3.90% | -3.33% | |
| Form S-3 Corbus Pharmaceuticals | SEC filing · Form S-3 | -1.95% | -4.48% | |
| Form 10-K Corbus Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.52% | +3.40% | |
| Form 8-K Corbus Pharmaceuticals For: Mar 09 | SEC filing · Form 8-K | +5.01% | +16.75% | |
| Form 8-K Corbus Pharmaceuticals For: Feb 25 | SEC filing · Form 8-K | +2.23% | +1.70% | |
| Form 8-K Corbus Pharmaceuticals For: Jan 12 | SEC filing · Form 8-K | -1.58% | -2.68% | |
| Form 8-K Corbus Pharmaceuticals For: Dec 12 | SEC filing · Form 8-K | -0.86% | -0.37% | |
| Form 8-K Corbus Pharmaceuticals For: Dec 11 | SEC filing · Form 8-K | +5.13% | -6.29% | |
| Form 10-Q Corbus Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.15% | — | |
| Form 8-K Corbus Pharmaceuticals For: Nov 12 | SEC filing · Form 8-K | +0.77% | +8.12% | |
| Form 8-K Corbus Pharmaceuticals For: Oct 30 | SEC filing · Form 8-K | +1.73% | +1.15% | |
| Form 8-K Corbus Pharmaceuticals For: Oct 30 | SEC filing · Form 8-K | +2.08% | +1.25% | |
| Form 8-K Corbus Pharmaceuticals For: Oct 18 | SEC filing · Form 8-K | -13.29% | -10.83% | |
| Form 8-K Corbus Pharmaceuticals For: Sep 16 | SEC filing · Form 8-K | -0.41% | +6.54% | |
| Form 10-Q Corbus Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.50% | +0.66% | |
| Form 8-K Corbus Pharmaceuticals For: Aug 05 | SEC filing · Form 8-K | +1.84% | -6.32% | |
| Form 8-K Corbus Pharmaceuticals For: May 15 | SEC filing · Form 8-K | -0.41% | +6.01% | |
| Form 10-Q Corbus Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -5.78% | -6.70% | |
| Form 8-K Corbus Pharmaceuticals For: May 06 | SEC filing · Form 8-K | -7.19% | -14.38% | |
| Form ARS Corbus Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +0.81% | +5.69% | |
| Form DEF 14A Corbus Pharmaceuticals For: May 15 | SEC filing · Form DEF | +0.81% | +5.69% | |
| Form DEFA14A Corbus Pharmaceuticals | SEC filing · Form DEFA14A | +0.81% | +5.69% | |
| Form 8-K Corbus Pharmaceuticals For: Mar 20 | SEC filing · Form 8-K | -0.34% | +0.85% | |
| Form 8-K Corbus Pharmaceuticals For: Mar 13 | SEC filing · Form 8-K | -3.41% | -6.51% | |
| Form 10-K Corbus Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.73% | +0.88% | |
| Form 8-K Corbus Pharmaceuticals For: Mar 11 | SEC filing · Form 8-K | +0.28% | -3.10% | |
| Form 8-K Corbus Pharmaceuticals For: Feb 14 | SEC filing · Form 8-K | +9.62% | +2.90% | |
| Form 8-K Corbus Pharmaceuticals For: Dec 03 | SEC filing · Form 8-K | -1.70% | -10.95% | |
| Form 8-K Corbus Pharmaceuticals For: Nov 15 | SEC filing · Form 8-K | +0.52% | +2.51% | |
| Form 10-Q Corbus Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +0.46% | +1.73% | |
| Form 8-K Corbus Pharmaceuticals For: Nov 07 | SEC filing · Form 8-K | -1.66% | -4.09% | |
| Form 8-K Corbus Pharmaceuticals For: Nov 04 | SEC filing · Form 8-K | +0.03% | +4.99% | |
| Form 8-K Corbus Pharmaceuticals For: Aug 29 | SEC filing · Form 8-K | -0.56% | +0.69% | |
| Form 8-K Corbus Pharmaceuticals For: Aug 15 | SEC filing · Form 8-K | -0.90% | -2.75% | |
| Form 10-Q Corbus Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -3.23% | -11.39% | |
| Form 8-K Corbus Pharmaceuticals For: Aug 06 | SEC filing · Form 8-K | +0.45% | -4.39% | |
| Form 8-K Corbus Pharmaceuticals For: Jun 14 | SEC filing · Form 8-K | +1.26% | -8.49% | |
| Form 8-K Corbus Pharmaceuticals For: Jun 01 | SEC filing · Form 8-K | +0.00% | +4.07% | |
| Form S-8 Corbus Pharmaceuticals | SEC filing · Form S-8 | +0.00% | +4.07% | |
| Form 8-K Corbus Pharmaceuticals For: May 16 | SEC filing · Form 8-K | +0.24% | -6.42% | |
| Form 8-K Corbus Pharmaceuticals For: May 09 | SEC filing · Form 8-K | -2.23% | +0.51% | |
| Form 10-Q Corbus Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +6.00% | |
| Form 8-K Corbus Pharmaceuticals For: May 07 | SEC filing · Form 8-K | -0.17% | +4.74% | |
| Form 8-K Corbus Pharmaceuticals For: Apr 10 | SEC filing · Form 8-K | -0.84% | +4.99% | |
| Form DEFA14A Corbus Pharmaceuticals | SEC filing · Form DEFA14A | -0.84% | +4.99% | |
| Form ARS Corbus Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +3.26% | +4.03% | |
| Form DEF 14A Corbus Pharmaceuticals For: Mar 29 | SEC filing · Form DEF | +3.26% | +4.03% | |
| Form DEFA14A Corbus Pharmaceuticals | SEC filing · Form DEFA14A | +3.26% | +4.03% | |
| Form PRE 14A Corbus Pharmaceuticals For: May 16 | SEC filing · Form PRE | -2.12% | -0.47% | |
| Form EFFECT Corbus Pharmaceuticals | SEC filing · Form EFFECT | +1.16% | -1.42% | |
| Form 10-K/A Corbus Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +1.16% | -1.42% | |
| Form 8-K Corbus Pharmaceuticals For: Mar 20 | SEC filing · Form 8-K | +1.16% | -1.42% | |
| Form S-3 Corbus Pharmaceuticals | SEC filing · Form S-3 | +1.18% | -0.40% | |
| Form 10-K Corbus Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +1.60% | +1.55% | |
| Form 8-K Corbus Pharmaceuticals For: Mar 12 | SEC filing · Form 8-K | +0.65% | +11.12% | |
| Form 8-K Corbus Pharmaceuticals For: Feb 02 | SEC filing · Form 8-K | -2.60% | -10.04% | |
| Form 8-K Corbus Pharmaceuticals For: Feb 05 | SEC filing · Form 8-K | +1.23% | +2.19% | |
| Form 8-K/A Corbus Pharmaceuticals For: Jan 30 | SEC filing · Form 8-K | +0.83% | +1.37% | |
| Form 8-K Corbus Pharmaceuticals For: Jan 30 | SEC filing · Form 8-K | +0.83% | +1.37% | |
| Form 8-K Corbus Pharmaceuticals For: Jan 30 | SEC filing · Form 8-K | -3.85% | -6.76% | |
| Form S-3MEF Corbus Pharmaceuticals | SEC filing · Form S-3MEF | -3.85% | -6.76% | |
| Form 8-K Corbus Pharmaceuticals For: Jan 29 | SEC filing · Form 8-K | -3.61% | -25.22% | |
| Form 8-K Corbus Pharmaceuticals For: Jan 26 | SEC filing · Form 8-K | +13.35% | +73.47% | |
| Form 8-K Corbus Pharmaceuticals For: Jan 08 | SEC filing · Form 8-K | -1.35% | -2.43% | |
| Form 8-K Corbus Pharmaceuticals For: Nov 14 | SEC filing · Form 8-K | +0.00% | +21.89% | |
| Form 8-K Corbus Pharmaceuticals For: Nov 10 | SEC filing · Form 8-K | — | +21.70% | |
| Form 10-Q Corbus Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -13.18% | |
| Form 8-K Corbus Pharmaceuticals For: Nov 07 | SEC filing · Form 8-K | +3.21% | -10.26% |
Keep exploring
More CRBP: earnings → · analyst actions → · CRBP overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Establishment Labs Holdings Inc. - Common Shares (ESTA) | 306 | +0.13% | 52% |
| Syndax Pharmaceuticals, Inc. (SNDX) | 306 | +0.04% | 51% |
| U.S. Physical Therapy, Inc. (USPH) | 304 | -0.03% | 46% |
| The Cooper Companies, Inc. (COO) | 303 | -0.21% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.